cigarette

Read more about the article Behavioral Interventions can help smokers with diabetes quit with a greater likelihood of success. However, structured programs are needed

Behavioral Interventions can help smokers with diabetes quit with a greater likelihood of success. However, structured programs are needed

The results were included in the review "Behavioural therapy for people with diabetes who smoke: a scoping review," published in the Journal of Primary Care and Community Health: it is now clear that persons living with diabetes are not the subject of targeted treatments and that there is ample room for progress. It seems that more structured and intensive therapies could benefit these persons in bidding farewell to cigarette smoking, while little is still known about the possible benefits of combining  behavioral therapies and nicotine replacement pharmacological therapies.

Continue ReadingBehavioral Interventions can help smokers with diabetes quit with a greater likelihood of success. However, structured programs are needed
Read more about the article CoEHAR study: smoking contributes to dental plaque and bad breath

CoEHAR study: smoking contributes to dental plaque and bad breath

Researchers compared measurements of dental plaque among current, former, and never smokers using an innovative light-induced fluorescence technology. Objective quantification of dental plaque was necessary to conduct reliable comparisons between smokers and non-smokers.

Continue ReadingCoEHAR study: smoking contributes to dental plaque and bad breath
Read more about the article Diabetes and smoking: international meeting on the development of new guidelines in Catania

Diabetes and smoking: international meeting on the development of new guidelines in Catania

Ten of the world’s leading experts in diabetes addressed the issue of smoking harm in this vulnerable population in its clinical, medical, behavioral and sociological implications, in order to provide independent consultation and oversight to the development of smoking cessation / harm reduction guidelines for smokers with type 2 diabetes mellitus.

Continue ReadingDiabetes and smoking: international meeting on the development of new guidelines in Catania
Read more about the article Impact of ENDS on oxidative stress: a Replica project review

Impact of ENDS on oxidative stress: a Replica project review

An independent review by the Replica project team examines the impact of tobacco smoke and electronic nicotine delivery systems use on oxidative stress, the precursor of the so-called tobacco related diseases (respiratory and cardiovascular diseases, tumors). To date, the scientific evidence available constitutes a puzzle of information, which, despite experimental and procedural limitations of international studies , already shows a reduced impact of ENDS on oxidative stress compared to cigarette smoking, even if some research have concluded that they do not completely eliminate it, leaving the question still pending 

Continue ReadingImpact of ENDS on oxidative stress: a Replica project review
Read more about the article Study showed that vaping is linked to respiratory symptoms but according to CoEHAR researchers: “No causality proved”

Study showed that vaping is linked to respiratory symptoms but according to CoEHAR researchers: “No causality proved”

The prestigious American Journal of Respiratory and Critical Care Medicine published a comment by researchers from CoEHAR and the University of Messina regarding a US studies that concluded that “former and current e-cigarette use was associated with higher odds of developing wheezing-related respiratory symptoms”. According to the Italian authors “the significance of the findings needs careful review”.

Continue ReadingStudy showed that vaping is linked to respiratory symptoms but according to CoEHAR researchers: “No causality proved”
Read more about the article First study in the world to evaluate efficacy and safety of the antismoking drug varenicline for smokers with Diabetes

First study in the world to evaluate efficacy and safety of the antismoking drug varenicline for smokers with Diabetes

A recent randomized controlled trial of varenicline (Chantix) combined with psychological support has significantly increased the chance of quitting smoking for 300 smokers with type 2 diabetes mellitus

Continue ReadingFirst study in the world to evaluate efficacy and safety of the antismoking drug varenicline for smokers with Diabetes
Read more about the article CoEHAR partnered with the giants of global pulmonology to develop a smoking and asthma algorithm to manage smokers with asthma

CoEHAR partnered with the giants of global pulmonology to develop a smoking and asthma algorithm to manage smokers with asthma

Overall, the study authors believe that smoking cessation has a positive effect on asthmatic patients' respiratory health: the longer you abstain from smoking, the better your asthma symptoms will be. Gradually, patients with asthma gain a higher quality of life as their exacerbations decrease.

Continue ReadingCoEHAR partnered with the giants of global pulmonology to develop a smoking and asthma algorithm to manage smokers with asthma
Read more about the article Cigarette smoking and SARS-CoV-2 infection: CoEHAR study found less infected people among current smokers
THE TROINA PROJECT

Cigarette smoking and SARS-CoV-2 infection: CoEHAR study found less infected people among current smokers

CoEHAR researchers investigated for the first time the relationship between biochemically-verified smoking status and SARS-CoV-2 infection in a large population study. The study “The impact of laboratory-verified smoking on SARS-CoV-2 infection: Results from the Troina sero-epidemiological survey”, found that the prevalence of SARS-CoV-2 antibody positivity were reduced in smokers compared to former and never smokers (19.8% vs. 31%)

Continue ReadingCigarette smoking and SARS-CoV-2 infection: CoEHAR study found less infected people among current smokers
Read more about the article Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project
alfio distefano experimental biology

Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project

CoEHAR presented the results of the Replica project during Experimental Biology 2022, the annual meeting that brings together thousands of scientists and experts in the field of anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. Representing CoEHAR, the researcher Alfio Distefano, PhD student in neuroscience at the University of Catania

Continue ReadingExperimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project